Find clinical trials for Lung Cancer in Louisville, KY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Louisville, KY, USA:
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Louisville, Kentucky, United States and 90 other locations
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...
Phase 2
Louisville, Kentucky, United States and 32 other locations
the efficacy and safety of an infusion of IOV-4001 in adult participants with unresectable or metastatic melanoma or advanced non-small-cell lung...
Phase 1, Phase 2
Louisville, Kentucky, United States and 9 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Louisville, Kentucky, United States and 210 other locations
The study is focused on patients who have advanced non-small cell lung cancer (NSCLC).The aims of this study are to see how safe an...
Phase 2
Louisville, Kentucky, United States and 52 other locations
as assessed by progression free survival (PFS) based on blinded independent central review (BCIR) per response evaluation criteria in solid tumors...
Phase 3
Louisville, Kentucky, United States and 206 other locations
This is a Phase 2b, multicenter, open-label study to evaluate the safety and efficacy of Sutetinib Maleate Capsule in Locally Advanced or Metastatic...
Phase 2
Louisville, Kentucky, United States and 25 other locations
overall response rate (ORR) when compared to nivolumab plus PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung...
Phase 2
Louisville, Kentucky, United States and 126 other locations
growth factor A (VEGF-A) in participants with non-small cell lung cancer (NSCLC).The study will comprise several cohorts for dose ...
Phase 1
Louisville, Kentucky, United States and 44 other locations
This is a Phase I, multicenter, open-label, dose escalation and dose expansion study to assess the safety and pharmacokinetic profile of PLB1004, a m...
Phase 1
Louisville, Kentucky, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal